Literature DB >> 23667206

Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology.

David S Ettinger, Gregory J Riely, Wallace Akerley, Hossein Borghaei, Andrew C Chang, Richard T Cheney, Lucian R Chirieac, Thomas A D'Amico, Todd L Demmy, Ramaswamy Govindan, Frederic W Grannis, Stefan C Grant, Leora Horn, Thierry M Jahan, Ritsuko Komaki, Feng-Ming Spring Kong, Mark G Kris, Lee M Krug, Rudy P Lackner, Inga T Lennes, Billy W Loo, Renato Martins, Gregory A Otterson, Jyoti D Patel, Mary C Pinder-Schenck, Katherine M Pisters, Karen Reckamp, Eric Rohren, Theresa A Shapiro, Scott J Swanson, Kurt Tauer, Douglas E Wood, Stephen C Yang, Kristina Gregory, Miranda Hughes.   

Abstract

Masses in the anterior mediastinum can be neoplasms (eg, thymomas, thymic carcinomas, or lung metastases) or non-neoplastic conditions (eg, intrathoracic goiter). Thymomas are the most common primary tumor in the anterior mediastinum, although they are rare. Thymic carcinomas are very rare. Thymomas and thymic carcinomas originate in the thymus. Although thymomas can spread locally, they are much less invasive than thymic carcinomas. Patients with thymomas have 5-year survival rates of approximately 78%. However, 5-year survival rates for thymic carcinomas are only approximately 40%. These guidelines outline the evaluation, treatment, and management of these mediastinal tumors.

Entities:  

Mesh:

Year:  2013        PMID: 23667206     DOI: 10.6004/jnccn.2013.0072

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  32 in total

1.  Pathologic Finding of Thymic Carcinoma Accompanied by Myasthenia Gravis.

Authors:  Se Hoon Kim; Im Suk Koh; Yang Ki Minn
Journal:  J Clin Neurol       Date:  2015-08-21       Impact factor: 3.077

2.  Rare cause of atrial fibrillation: a thymic mass.

Authors:  Swati Vishwanathan; Pritam Tayshetye; Farshaad Bilimoria; Gene Finley
Journal:  BMJ Case Rep       Date:  2016-07-14

3.  Treatment and prognostic factors of patients with thymic epithelial tumors at first recurrence or progression.

Authors:  Giuseppe L Banna; Ankur Sheel; Varun Sheel; Andrea Bille; Tom Routledge; Shalini Fernando; Arjun Nair; Rohit Lal
Journal:  Future Oncol       Date:  2017-11-10       Impact factor: 3.404

4.  Thoracoscopic lobectomy after induction therapy-a paradigm shift?

Authors:  Sameer A Hirji; Asishana Osho; Stafford S Balderson; Thomas A D'Amico
Journal:  J Vis Surg       Date:  2017-12-21

5.  Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.

Authors:  Ryo Ko; Takehito Shukuya; Yusuke Okuma; Kazunari Tateishi; Hisao Imai; Shunichiro Iwasawa; Eisaku Miyauchi; Akiko Fujiwara; Tomohide Sugiyama; Keisuke Azuma; Keiko Muraki; Masahiro Yamasaki; Hisashi Tanaka; Yuta Takashima; Sayo Soda; Osamu Ishimoto; Nobuyuki Koyama; Satoshi Morita; Kunihiko Kobayashi; Toshihiro Nukiwa; Kazuhisa Takahashi
Journal:  Oncologist       Date:  2018-03-22

6.  Invasive thymoma extending to the right atrium with superior vena cava syndrome presenting massive intracardiac thrombosis immediately after the start of chemotherapy: an autopsy case report.

Authors:  Maki Asami-Noyama; Tomoko Furuya-Kondo; Ryo Suetake; Kazuki Matsuda; Keiji Oishi; Yoshikazu Yamaji; Tsunahiko Hirano; Tomoyuki Kakugawa; Hiroshi Itoh; Kazuto Matsunaga
Journal:  Int Cancer Conf J       Date:  2022-02-28

7.  Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations.

Authors:  Yusuke Okuma; Yukio Hosomi; Kageaki Watanabe; Satoshi Takahashi; Tatsuru Okamura; Tsunekazu Hishima
Journal:  Int J Clin Oncol       Date:  2015-12-08       Impact factor: 3.402

8.  Verification of the diagnostic strategy for anterior mediastinal tumors.

Authors:  Shuhei Hakiri; Koji Kawaguchi; Takayuki Fukui; Shota Nakamura; Naoki Ozeki; Shunsuke Mori; Masaki Goto; Kumiko Hashimoto; Toshinari Ito; Kohei Yokoi
Journal:  Int J Clin Oncol       Date:  2018-10-29       Impact factor: 3.402

9.  Myasthenia gravis as a prognostic marker in patients with thymoma.

Authors:  Bernardo Cacho-Díaz; Karen Salmerón-Moreno; Nydia A Lorenzana-Mendoza; Julia Texcocano; Oscar Arrieta
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

10.  Chemoradiotherapy for unresectable cases of thymic epithelial tumors: a retrospective study.

Authors:  Jumpei Kashima; Yusuke Okuma; Hiroto Murata; Kageaki Watanabe; Yukio Hosomi; Tsunekazu Hishima
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.